DEF 14ATCRXCIK 0001783328
TScan Therapeutics, Inc.
Proxy statement (DEF 14A) filed .
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
New to the DEF 14A? What it is and how to read oneFiling facts
- Accession number
- 0001193125-26-431045
- Filer
- TScan Therapeutics, Inc.
- Ticker
- TCRX
- CIK
- 0001783328
- Form type
- DEF 14A
- Form description
- Proxy statement
- Filed at
- October 26, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- October 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from TScan Therapeutics, Inc.
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1783328/000119312526431045/0001193125-26-431045-index.htm ↗Filer's full EDGAR submission history
EDGAR · TScan Therapeutics, Inc. (0001783328) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001193125-26-431045.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.